Koers Standard BioTools Inc.
Aandelen
LAB
US34385P1084
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,535 USD | -2,87% | -12,71% | +14,93% |
Omzet 2024 * | 201 mln. 189 mln. | Omzet 2025 * | 232 mln. 218 mln. | Marktkapitalisatie | 998 mln. 938 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -161 mln. -151 mln. | Nettowinst (verlies) 2025 * | -69 mln. -64,81 mln. | EV/omzet 2024 * | 4,97 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,3 x |
K/w-verhouding 2024 * |
-6,07
x | K/w-verhouding 2025 * |
-14,5
x | Werknemers | 537 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,94% |
Recentste transcriptie over Standard BioTools Inc.
1 dag | -2,87% | ||
1 week | -12,71% | ||
Lopende maand | -6,27% | ||
1 maand | -1,93% | ||
3 maanden | +10,92% | ||
6 maanden | +31,61% | ||
Lopend jaar | +14,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 04-04-22 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 15-05-23 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | 05/01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 01-04-22 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 15-03-23 |
Kathy Hibbs
BRD | Director/Board Member | 60 | 05/01 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 2,54 | -2,68% | 1 728 949 |
17-04-24 | 2,61 | -3,69% | 3 703 485 |
16-04-24 | 2,71 | -2,17% | 2 672 336 |
15-04-24 | 2,77 | -0,72% | 2 170 470 |
12-04-24 | 2,79 | -4,12% | 2 413 862 |
uitgestelde koers Nasdaq, 18 april 2024 om 20:20 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,93% | 998 mln. | |
+1,95% | 209 mld. | |
+2,37% | 177 mld. | |
+10,73% | 133 mld. | |
+16,90% | 99,89 mld. | |
-2,70% | 61,83 mld. | |
+13,48% | 52,51 mld. | |
-6,33% | 45,54 mld. | |
-4,49% | 39,43 mld. | |
+10,05% | 38,87 mld. |